World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
96
Citations
30417
World Ranking
1841
National Ranking
1012

Iannis Aifantis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Iannis Aifantis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 299 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Iannis Aifantis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Iannis Aifantis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 96 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Iannis Aifantis is affiliated with New York University in the United States. Their research primarily spans the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. Within these broad disciplines, Aifantis's work focuses on subfields including Molecular Biology, Immunology, Hematology, Oncology, and Cancer Research.

Their research addresses several main topics, notably:

  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Histone Deacetylase Inhibitors Research
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Acute Lymphoblastic Leukemia research

Aifantis has contributed to numerous scientific publications. Their recent papers include:

  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML (2020) published in Blood
  • Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis (2020) published in Cancer Cell
  • RNA Splicing and Cancer (2020) published in Trends in cancer
  • Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia (2020) published in Nature Genetics
  • A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation (2022) published in Nature

The frequent publication venues for Aifantis include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Immunology
  • Blood Cancer Discovery
  • Nature Communications

Aifantis often collaborates with several researchers, notably:

  • Aristotelis Tsirigos
  • Matthew T. Witkowski
  • Eric Wang
  • Xufeng Chen
  • Audrey Lasry

Best Publications

  • Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

    Kelly Moran-Crusio;Linsey Reavie;Alan Shih;Omar Abdel-Wahab

  • The bone marrow microenvironment at single-cell resolution.

    Anastasia N. Tikhonova;Igor Dolgalev;Hai Hu;Kishor K Sivaraj

  • ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

    Omar Abdel-Wahab;Mazhar Adli;Lindsay M. LaFave;Jie Gao

  • Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression

    Luisa Cimmino;Igor Dolgalev;Yubao Wang;Akihide Yoshimi

  • Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia

    Panagiotis Ntziachristos;Panagiotis Ntziachristos;Aristotelis Tsirigos;Pieter Van Vlierberghe;Jelena Nedjic

  • The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia

    Benjamin J. Thompson;Silvia Buonamici;Maria Luisa Sulis;Teresa Palomero

  • SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

    Eunhee Kim;Janine O. Ilagan;Yang Liang;Gerrit M. Daubner

  • Molecular pathogenesis of T-cell leukaemia and lymphoma

    Iannis Aifantis;Elizabeth Raetz;Silvia Buonamici

  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.

    C. D. DiNardo;I. S. Tiong;I. S. Tiong;A. Quaglieri;S. MacRaild

  • γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

    Pedro J Real;Valeria Tosello;Teresa Palomero;Teresa Palomero;Mireia Castillo

  • Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.

    Tomas Vilimas;Joaquina Mascarenhas;Teresa Palomero;Malay Mandal

  • Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma

    Ximena Bonilla;Laurent Parmentier;Bryan King;Fedor Bezrukov;Fedor Bezrukov

  • Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia

    Thomas Trimarchi;Thomas Trimarchi;Erhan Bilal;Panagiotis Ntziachristos;Panagiotis Ntziachristos;Giulia Fabbri

  • A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

    Apostolos Klinakis;Camille Lobry;Omar Abdel-Wahab;Philmo Oh

  • From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling

    Panagiotis Ntziachristos;Jing Shan Lim;Julien Sage;Iannis Aifantis;Iannis Aifantis

  • Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think

    Camille Lobry;Philmo Oh;Iannis Aifantis

  • Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

    Ewa Sicinska;Iannis Aifantis;Laurent Le Cam;Wojciech Swat

  • Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia

    Panagiotis Ntziachristos;Panagiotis Ntziachristos;Aristotelis Tsirigos;G. Grant Welstead;Thomas Trimarchi

  • Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

    Omar Abdel-Wahab;Jie Gao;Mazhar Adli;Anwesha Dey

  • Genome-wideMappingandCharacterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia

    Thomas Trimarchi;Erhan Bilal;Panagiotis Ntziachristos;Giulia Fabbri

Frequent Co-Authors

Aristotelis Tsirigos
Aristotelis Tsirigos New York University
Omar Abdel-Wahab
Omar Abdel-Wahab Memorial Sloan Kettering Cancer Center
Adolfo A. Ferrando
Adolfo A. Ferrando Columbia University
Ross L. Levine
Ross L. Levine Memorial Sloan Kettering Cancer Center
Harald von Boehmer
Harald von Boehmer Harvard University
Ari Melnick
Ari Melnick Cornell University
Fotini Gounari
Fotini Gounari University of Chicago
Ira J. Goldberg
Ira J. Goldberg New York University
Jane A. Skok
Jane A. Skok New York University
Charles G. Mullighan
Charles G. Mullighan St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Biology or Biochemistry in the USA, there are many online degree and certificate programs to complement your career goals. An increasingly popular option is the cheapest online mba healthcare, which provides advanced knowledge in healthcare management and can open the door to leadership roles in biotech and medical organizations.

In terms of specialized career paths, medical coding and billing offer stable job prospects and flexibility. To advance, many professionals pursue a ccs certification, which qualifies you for higher salaries and more complex roles. If you’re curious about the earning potential, explore the latest data on medical.coder salary to see average incomes and growth opportunities in this field.

Considering a job in this area? It’s helpful to weigh all aspects. Discover whether is medical billing and coding a good career for your aspirations, as this field offers advantages like remote work and job security—alongside a few challenges to keep in mind.

Best Scientists Citing Iannis Aifantis

Trending Scientists

Recently Published Articles